Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis

Overview of attention for article published in Frontiers in endocrinology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,691 followers.

@StrokeAHA_ASA @AANmember @TjuhNeurology @MicieliA_MD @a_charidimou @AshuPJadhav @nbavar https://t.co/IiF4XngMFC. https://t.co/eAIK7quQlR https://t.co/MzWqDyqkrg

28 Sep 2023

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCT…

06 Dec 2022

Reply Repost Favourite

New Research: Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis: Purpose To explore the risk of stroke (including ischemic and hemorrhagic stroke) in type 2… https://t.co/oTEDb5UWUX #En

05 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.